-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
June 01, 2016 - Treating Infantile Hemangiomas in Children
Treating Infantile
Hemangiomas in Children
A Review of … treatment
� The cost of the treatment
Ask your child’s health care professional
� Do you recommend treating
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
October 03, 2019 - Skin Substitutes for Treating Chronic Wounds
Evidence-based Practice Center Technical Brief Protocol … Project Title: Skin Substitutes for Treating Chronic Wounds
Initial publication date: November 27 … Are there situations in which a clinician should not use a skin substitute when treating
chronic wounds … analyses published since 2012, the publications date of the evidence report “Skin
Substitutes for Treating … Skin substitutes for treating chronic wounds. Final report.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
May 01, 2017 - Treating and Preventing C. difficile Infections
Treating and Preventing
C. difficile Infections
A
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
August 01, 2016 - Treating Disruptive Behavior Disorders in Children and Teens
Treating Disruptive Behavior
Disorders
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy
Source: https:/ … Effectiveness Review Disposition of Comments Report
Research Review Title: Preventing Complications and Treating … Preventing
Complications and Treating Symptoms of Diabetic Peripheral Neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy
Source: https:/ … Effectiveness Review Disposition of Comments Report
Research Review Title: Preventing Complications and Treating … Preventing
Complications and Treating Symptoms of Diabetic Peripheral Neuropathy.
-
effectivehealthcare.ahrq.gov/products/binge-eating/consumer
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/consumer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_consumer.pdf
May 01, 2016 - Treating Binge-Eating Disorder. … A Review of Evidence for Adults
Treating Binge-Eating
Disorder
A Review of the Research for Adults
-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/consumer
-
effectivehealthcare.ahrq.gov/products/c-difficile-update/consumer
-
effectivehealthcare.ahrq.gov/products/skin-substitutes/protocol
-
effectivehealthcare.ahrq.gov/products/diabetic-neuropathy/research-2017
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
December 22, 2014 - , as the first IFN-free treatment option with RBV for treating genotypes 2 or 3. … or 6 infection; ledipasvir/sofosbuvir for treating HCV genotype 1 infection,
daclatasvir for treating … Recommendations for testing,
managing, and treating hepatitis C. … HS1730 -
Ledipasvir for treating chronic hepatitis C
infection. 2014 Jun 19.
76. … HS1730 - Ledipasvir for treating chronic
hepatitis C infection. 2014 Jul 11.
79.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
December 01, 2015 - ; Harvoni for treating HCV genotype 1 or 4 infection, Viekira Pak for
treating chronic genotype 1 or … 4 infection, and Daklinza for treating genotype 1, 2, 3, 4, 5, or
6 infection. … HS1730 - Ledipasvir for treating
chronic hepatitis C infection. 2014 Jun 19.
88. … HS1730 - Ledipasvir for treating chronic
hepatitis C infection. 2014 Jun 17.
89. … HS1730 - Ledipasvir
for treating chronic hepatitis C infection. 2014
Jun 17.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
January 28, 2016 - Experts also deemed seven drugs for treating chronic HCV infection as having
high-impact potential: … To date, FDA has
approved DAAs for treating patients who are infected with HCV genotypes 1 through … Grazoprevir/elbasvir is being evaluated in several phase II and III
trials for treating chronic HCV … It was approved in combination with RBV for treating
chronic HCV genotype 2 or 3 infection. … Recommendations for
testing, managing, and treating hepatitis C.
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - This report addresses two topics, both off-label pharmacotherapies with potential use for
treating … are pursuing labeling for treating BPD or MDD, and third-party
payers generally do not reimburse its … Several ongoing, large clinical trials are investigating ketamine’s efficacy for
treating MDD, BPD, … MDD and are used
as monotherapies or in combination regimens.54-56 For treating BPD, anticonvulsants … Glutamatergic modulators: the future of treating
mood disorders?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
November 01, 2016 - Pharmacological interventions: Nonsteroidal anti-
inflammatory drugs (NSAIDs) may be effective in
treating … low back pain (see Table 2)
�� Nonpharmacological interventions: Superficial heat
is effective in treating … Exercise,
acupuncture, spinal manipulation, and multidisciplinary
rehabilitationa are effective in treating … moderate SOE).
�� Pharmacological interventions: NSAIDs, opioids, and
duloxetine are effective in treating … their
low back pain
�� The limited evidence for the benefits of opioids in
treating chronic low back
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Five phase III trials on secukinumab for treating AS are ongoing. … In January 2015, secukinumab was approved for treating plaque
psoriasis. … If approved for treating AS,
secukinumab would likely be covered for treating patients with active … Four phase III trials on secukinumab for treating PsA are ongoing. … treating
PsA are expected in 2015.